- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/10 - Anthelmintics
Patent holdings for IPC class A61P 33/10
Total number of patents in this class: 451
10-year publication summary
27
|
20
|
20
|
19
|
28
|
46
|
34
|
41
|
28
|
12
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bayer Animal Health GmbH | 300 |
27 |
Intervet International B.V. | 1235 |
26 |
Elanco Tiergesundheit AG | 452 |
20 |
Intervet Inc. | 848 |
16 |
Nihon Nohyaku Co., Ltd. | 313 |
15 |
Boehringer Ingelheim Animal Health USA Inc. | 507 |
15 |
Nippon Soda Co., Ltd. | 890 |
14 |
Elanco Animal Health GmbH | 225 |
11 |
Boehringer Ingelheim Vetmedica GmbH | 1290 |
9 |
CEVA Sante Animale | 683 |
9 |
The Governing Council of The University of Toronto, | 1361 |
9 |
Sumitomo Chemical Company, Limited | 8808 |
8 |
University of Massachusetts | 2130 |
8 |
Zoetis LLC | 45 |
6 |
Bomac Research Limited | 15 |
6 |
Boehringer Ingelheim Pharma GmbH & Co. Kg | 790 |
5 |
Celgene Corporation | 1412 |
5 |
Elanco US Inc. | 698 |
5 |
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 357 |
5 |
Merial Limited | 158 |
5 |
Other owners | 227 |